Related Experiment Video
Updated: Jan 23, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Oncolytic Measles Virotherapy and Opposition to Measles Vaccination
Stephen J Russell1, Dusica Babovic-Vuksanovic2, Alice Bexon3
1Department of Molecular Medicine, Mayo Clinic, Rochester, MN; Division of Hematology, Mayo Clinic, Rochester, MN.
Abstract:
Recent measles epidemics in US and European cities where vaccination coverage has declined are providing a harsh reminder for the need to maintain protective levels of immunity across the entire population. Vaccine uptake rates have been declining in large part because of public misinformation regarding a possible association between measles vaccination and autism for which there is no scientific basis. The purpose of this article is to address a new misinformed antivaccination argument-that measles immunity is undesirable because measles virus is protective against cancer. Having worked for many years to develop engineered measles viruses as anticancer therapies, we have concluded (1) that measles is not protective against cancer and (2) that its potential utility as a cancer therapy will be enhanced, not diminished, by prior vaccination.
Insights
Measles vaccination is crucial for public health, despite misinformation linking it to autism. Measles infection does not protect against cancer; vaccination may enhance future cancer therapies.
Area of Science:
- Immunology
- Virology
- Oncology
Background:
- Declining vaccination rates have led to resurgent measles outbreaks.
- Misinformation about measles vaccination and autism persists, lacking scientific evidence.
- A new antivaccination argument claims measles immunity is protective against cancer.
Purpose of the Study:
- To refute the claim that measles infection is protective against cancer.
- To address the impact of vaccination on potential measles virus-based cancer therapies.
Main Methods:
- Review of scientific literature on measles virus and cancer.
- Analysis of the effects of pre-existing immunity on oncolytic measles virus therapy.
Main Results:
- Measles infection is not protective against cancer.
- Prior vaccination does not hinder, but may improve, the efficacy of measles virus as a cancer therapy.
Conclusions:
- Measles vaccination is essential for maintaining population immunity and preventing outbreaks.
- The claim that measles protects against cancer is scientifically unfounded.
- Vaccination is compatible with and potentially beneficial for measles virus-based cancer treatments.
Related Concept Videos
Vaccinations
Oppositional Defiant Disorder
Diagnostic Criteria and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
What is an Electrochemical Gradient?
The chemical gradient relies on differences in the abundance of a substance on the outside versus the inside of a cell and flows from areas of high to low ion concentration. In contrast, the electrical gradient revolves around an...
Electrolyte and Nonelectrolyte Solutions
Bond Polarity, Dipole Moment, and Percent Ionic Character

